Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Riboflavin 5 Phosphate Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 7 USDMF, 3 CEP/COS, 5 JDMF, 2 EU WC, 9 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 15 FDA Orange Book, 15 Europe, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 14 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders, 25 Parenteral, 18 Solubilizers, 17 Taste Masking, 14 Film Formers & Plasticizers, 13 Chewable & Orodispersible Aids, 12 Topical, 11 Thickeners and Stabilizers, 11 Direct Compression, 8 Empty Capsules, 7 Coating Systems & Additives, 7 Disintegrants & Superdisintegrants, 6 Surfactant & Foaming Agents, 5 Emulsifying Agents, 4 Co-Processed Excipients, 3 Granulation, 2 Coloring Agents, 1 Rheology Modifiers, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 4 News #PharmaBuzz

MARKET PLACE

16 APIs, 1 EXCIPIENTS

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Harman Finochem	India	HARMAN FINOCHEM LIMITED Mumbai IN	CEP 2010-254 - Rev 03	Riboflavin sodium phosphate hydrate	2025-03-28	Valid	Chemical		786
29/11/2025	Royal DSM	Netherlands	DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH	CEP 2023-436 - Rev 01	Riboflavin sodium phosphate hydrate	2025-07-17	Valid	Chemical		786

Riboflavin 5 Phosphate Sodium

Riboflavin 5 Phosphate Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

20 API Suppliers

7 USDMF

3 CEP/COS

5 JDMF

2 EU WC

9 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers

15 FDA Orange Book

15 Europe

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

14 SPI Pharma

6 DKSH

1 Pharm-RX Chemical

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Kirsch Pharma

4 ACG Worldwide

6 Actylis

4 BASF

1 Bioplus Life Sciences

1 CD Formulation

2 Finar

6 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Nanjing Bold Chemical

3 Pluviaendo

1 Qualicaps

14 Roquette

8 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders

25 Parenteral

18 Solubilizers

17 Taste Masking

14 Film Formers & Plasticizers

13 Chewable & Orodispersible Aids

12 Topical

11 Thickeners and Stabilizers

11 Direct Compression

8 Empty Capsules

7 Coating Systems & Additives

7 Disintegrants & Superdisintegrants

6 Surfactant & Foaming Agents

5 Emulsifying Agents

4 Co-Processed Excipients

3 Granulation

2 Coloring Agents

1 Rheology Modifiers

1 Soft Gelatin